H16.33 Sclerosing keratitis

Name of the Condition

• Sclerosing Keratitis

Summary

Sclerosing keratitis is a chronic inflammatory condition characterized by progressive scarring and hardening of the corneal tissue. This process can lead to corneal opacity, reduced vision, and structural changes that may impair ocular function. The condition may be associated with underlying systemic or ocular diseases and requires ongoing monitoring to manage complications.

Causes

Sclerosing keratitis can develop secondary to infectious processes, such as syphilis, tuberculosis, or herpes simplex virus, or non-infectious conditions like autoimmune disorders (e.g., rheumatoid arthritis, sarcoidosis) or chronic ocular inflammation. In some cases, the cause remains idiopathic, and the condition progresses without a clear underlying trigger.

Risk Factors

• History of systemic infections (e.g., syphilis, tuberculosis).
• Autoimmune diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus).
• Chronic ocular inflammation or prior keratitis.
• Prolonged use of topical medications, including steroids.
• Genetic predisposition to inflammatory or connective tissue disorders.
• Prior eye surgery or trauma.

Symptoms

• Gradual vision loss or blurring.
• Corneal opacity or clouding.
• Eye redness or irritation.
• Sensitivity to light (photophobia).
• Mild discomfort or a feeling of a foreign body in the eye.
• Possible distortion of vision (e.g., halos around lights).

Diagnosis

Diagnosis is based on a comprehensive eye examination, including slit-lamp microscopy to assess corneal scarring and opacity. Additional tests, such as corneal topography or anterior segment imaging, may be used to evaluate structural changes. Laboratory workup (e.g., serology, cultures) may be performed to identify underlying infectious or systemic causes.

Treatment Options

Treatment focuses on managing the underlying cause and reducing inflammation. Topical or systemic anti-inflammatory medications (e.g., corticosteroids) may be prescribed to slow progression. In advanced cases, corneal transplantation or other surgical interventions may be necessary to restore vision. Regular follow-up is essential to monitor disease activity.

Prognosis and Follow-Up

Prognosis varies depending on the underlying cause and severity of corneal involvement. Early intervention can help preserve vision, but advanced scarring may lead to permanent visual impairment. Long-term follow-up with an ophthalmologist is recommended to assess disease progression and adjust treatment as needed.

Complications

• Permanent corneal scarring and vision loss.
• Corneal thinning or perforation.
• Secondary infections due to corneal breakdown.
• Glaucoma or cataract development.
• Chronic eye pain or discomfort.

Lifestyle & Prevention

• Protect the eyes from injury or infection (e.g., avoid rubbing, use protective eyewear).
• Manage underlying systemic conditions (e.g., autoimmune diseases) with appropriate treatment.
• Follow prescribed medication regimens to control inflammation.
• Avoid prolonged use of contact lenses if corneal health is compromised.
• Maintain good ocular hygiene and avoid irritants (e.g., smoke, dust).

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision loss, severe eye pain, increased redness, or signs of infection (e.g., discharge, swelling). Regular check-ups are advised for those with a history of corneal disease or systemic conditions that increase risk.

Tips for Medical Coders

When coding for sclerosing keratitis (H16.33), ensure documentation supports the diagnosis, including clinical findings (e.g., corneal scarring, opacity) and any associated underlying conditions. Note the eye laterality (e.g., right, left, bilateral) if specified, as this may impact code assignment. Verify that the code aligns with the provider’s clinical assessment and avoid using this code for acute or non-sclerosing forms of keratitis.